A comparative study of Olanzapine and Haloperidol in treating Delirium in ICU settings
Phase 3
- Conditions
- Health Condition 1: F01-F09- Mental disorders due to known physiological conditions
- Registration Number
- CTRI/2023/03/051110
- Lead Sponsor
- Pacific Medical College and Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
1.Patients in ICU (medical and surgical) diagnosed with Delirium
2.Patients of both genders, above 18 years of age
3.Patients whose primary caregiver (legally authorized representative) has given consent for the patientâ??s inclusion in the study
4.Patients who stayed in the ICU for a minimum of 72 hours
Exclusion Criteria
1.Patients whose caregivers did not give consent
2.Patients of Delirium purely due to complicated Alcohol Withdrawal
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method